Preparation and Characterization of Methylene blue Nanoparticles for Alzheimer’s Disease and Other Tauopathies

Publisher： Bentham Science Publishers

E-ISSN： 1875-5704|11|4|541-550

ISSN： 1567-2018

Source： Current Drug Delivery, Vol.11, Iss.4, 2014-06, pp. : 541-550

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Preparation and Characterization of MKT-077 Nanoparticles for Treatment of Alzheimer’s Disease and Other Tauopathies

By  

Pharmaceutical Nanotechnology, Vol. 2, Iss. 4, 2014-12 ,pp. : 217-226

Bentham Science Publishers

Access to resources Recommend Favorite

Current strategies for the treatment of Alzheimer’s disease and other tauopathies

By Dickey Chad A   Petrucelli Leonard  

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 5, 2006-10 ,pp. : 665-676

Informa Healthcare

Access to resources Recommend Favorite

Preparation, characterization, in vivo and biochemical evaluation of brain targeted Piperine solid lipid nanoparticles in an experimentally induced Alzheimer’s disease model

By Yusuf Mohammad   Khan Maria   Khan Riaz A.   Ahmed Bahar  

Journal of Drug Targeting, Vol. 21, Iss. 3, 2013-04 ,pp. : 300-311

Informa Healthcare

Access to resources Recommend Favorite

Inhibition of Neurofibrillary Degeneration: A Promising Approach to Alzheimer's Disease and Other Tauopathies

By  

Current Drug Targets, Vol. 5, Iss. 6, 2004-08 ,pp. : 495-502

Bentham Science Publishers

Access to resources Recommend Favorite

Tocopherol (Vitamin E) in Alzheimer’s Disease and Other Neurodegenerative Disorders

By Karen Berman   Henry Brodaty  

CNS Drugs, Vol. 18, Iss. 12, 2004-01 ,pp. : 807-825

Adis International

Access to resources Recommend Favorite